Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials

Overview of attention for article published in PLOS ONE, June 2011

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 152 Dimensions

Readers on

mendeley: 134 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 152 publications that cite this research output.

152

The most recent citing publications are shown below. View all 152 publications that cite this research output on Dimensions.

Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis

Article in Frontiers in Pharmacology (April 2023)

Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period

Article in Journal of Cancer Research and Clinical Oncology (December 2022)

Cancer therapy by antibody-targeted Cerenkov light and metabolism-selective photosensitization

Article in Journal of Controlled Release (October 2022)